Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Long

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|April 20, 1988
Phase II evaluation of carboplatin in advanced endometrial carcinomaH J Long, D M Pfeifle, H S Wieand, et al.
Cancer Treatment Reports|February 1, 1987
Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinomaJ H Edmonson, G W McCormack, J E Krook, et al.
Cancer|January 15, 1993
Localized ovarian cancer in the elderly. The Gynecologic Oncology Group experienceR C Young, M F Brady, L A Walton, et al.
Journal of the National Cancer Institute|October 4, 1989
Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependencyJ H Edmonson, H J Long, J A Jeffries, et al.
Chronobiologia|October 1, 1991
Toward a chronotherapy of ovarian cancer with taxol. Part I: Basic backgroundG Cornélissen, E Halberg, H J Long, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 6, 2000
Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model systemT A Davies, H J Long, P B Eisenhauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Cancer|August 15, 1991
A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo ClinicH J Long, J A Laurie, H S Wieand, et al.
Cancer|December 15, 1984
Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Chronobiologia|October 1, 1991
Marker rhythmometry with macrophage-colony stimulating factor (M-CSF)S Elg, E Halberg, S Ramakrishnan, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|April 20, 1988
Phase II evaluation of carboplatin in advanced endometrial carcinomaH J Long, D M Pfeifle, H S Wieand, et al.
Cancer Treatment Reports|February 1, 1987
Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinomaJ H Edmonson, G W McCormack, J E Krook, et al.
Cancer|January 15, 1993
Localized ovarian cancer in the elderly. The Gynecologic Oncology Group experienceR C Young, M F Brady, L A Walton, et al.
Journal of the National Cancer Institute|October 4, 1989
Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependencyJ H Edmonson, H J Long, J A Jeffries, et al.
Chronobiologia|October 1, 1991
Toward a chronotherapy of ovarian cancer with taxol. Part I: Basic backgroundG Cornélissen, E Halberg, H J Long, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 6, 2000
Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model systemT A Davies, H J Long, P B Eisenhauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Cancer|August 15, 1991
A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo ClinicH J Long, J A Laurie, H S Wieand, et al.
Cancer|December 15, 1984
Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Chronobiologia|October 1, 1991
Marker rhythmometry with macrophage-colony stimulating factor (M-CSF)S Elg, E Halberg, S Ramakrishnan, et al.
Pageof 8